2022年8月25日 · Healthy people ages 2 through 49 can get the nasal spray flu vaccine. If you are pregnant, you should get a flu shot, not a nasal spray flu vaccine. Learn about the nasal spray flu vaccine, its benefits, potential side effects, and who should and should not receive it.

The live attenuated vaccine is based on a flu strain that does not cause disease, that replicates well at relatively cold temperatures (about 25 °C, for incubation purposes), and replicates poorly at body temperature (which minimizes risk to humans).

2025年2月28日 · Live, attenuated influenza vaccine (called "LAIV") is a nasal spray vaccine that may be given to men and non-pregnant women 2 through 49 years of age. It takes about 2 weeks for protection to develop after vaccination. There are …

Live attenuated influenza vaccine (LAIV), commercially available since 2003, has not gained widespread acceptance among prescribers. This underuse can be traced to several misperceptions and fears regarding LAIV. This review examines both the facts (safety, immunogenicity, and effectiveness) and the most pervasive myths about LAIV.

In the United States, two types of vaccines are recommended for the prevention of influenza: an intranasal live attenuated influenza vaccine (LAIV) for eligible individuals aged 2-49 years and unadjuvanted injectable trivalent inactivated vaccines (TIV) for eligible individuals aged ≥ …

Live attenuated, cold-adapted influenza vaccines exhibit several desirable characteristics, including the induction of systemic, mucosal, and cell-mediated immunity resulting in breadth of protection, ease of administration, and yield.

Studies conducted before the licensure of LAIV show that it is protective against influenza disease in both adults and children. Several study findings are summarized below: In one large study conducted among children aged 15-85 months, LAIV reduced cases of influenza illness by 92%.

Since 2003 (US) and 2012 (Europe) the live attenuated influenza vaccine (LAIV) has been used as an alternative to the traditional inactivated influenza vaccines (IIV). The immune responses elicted by LAIV mimic natural infection and have been found to provide broader clinical protection in children compared to the IIVs.

2024年7月10日 · This PGD template supports the administration of live attenuated influenza vaccine (LAIV) (Fluenz Trivalent®) as part of the national seasonal influenza vaccination programme. LAIV PGD version...

2021年9月1日 · Live attenuated, cold-adapted influenza vaccines exhibit several desirable characteristics, including the induction of systemic, mucosal, and cell-mediated immunity resulting in breadth of protection, ease of administration, and yield. Seasonal live attenuated influenza vaccines (LAIVs) were develop …